Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: Implications for cell-based therapy

Molecular Therapy

Volumn 21, Issue 9, 2013, Pages 1758-1766

  Bagó, Juli R ^a   Alieva, Maria ^a   Soler, Carolina ^b   Rubio, Núria ^a   Blanco, Jerónimo ^a  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; SHORT HAIRPIN RNA; THYMIDINE KINASE;

ADIPOSE TISSUE DERIVED MESENCHYMAL STROMAL CELL THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BIOLUMINESCENCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HOMING; CELL KILLING; CELL LINEAGE; CELL THERAPY; CONTROLLED STUDY; FLUORESCENCE IMAGING; GLIOMA; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TISSUE INTERACTION; TUMOR VASCULARIZATION;

SIMPLEXVIRUS;

ADIPOSE TISSUE; BYSTANDER EFFECT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEOPLASTIC STEM CELLS; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING;

EID: 84883742123     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.145     Document Type: Article

References (42)

1. Argyriou, AA and Kalofonos, HP (2009). Molecularly targeted therapies for malignant gliomas. Mol Med 15: 115-122.
2. Buckner, JC, Brown, PD, O'Neill, BP, Meyer, FB, Wetmore, CJ and Uhm, JH (2007). Central nervous system tumors. Mayo Clin Proc 82: 1271-1286. (Pubitemid 47502884)
3. Castro, MG, Cowen, R, Williamson, IK, David, A, Jimenez-Dalmaroni, MJ, Yuan, X et al. (2003). Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 98: 71-108. (Pubitemid 36349762)
4. Winkler, F, Kienast, Y, Fuhrmann, M, Von Baumgarten, L, Burgold, S, Mitteregger, G et al. (2009). Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia 57: 1306-1315.
5. Amberger-Murphy, V (2009). Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9: 381-390.
6. Dong, J and Huang, Q (2011). Targeting glioma stem cells: enough to terminate gliomagenesis? Chin Med J 124: 2756-2763.
7. Calabrese, C, Poppleton, H, Kocak, M, Hogg, TL, Fuller, C, Hamner, B et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82. (Pubitemid 46054518)
8. Christensen, K, Schrer, HD and Kristensen, BW (2008). CD133 identifies perivascular niches in grade II-IV astrocytomas. J Neurooncol 90: 157-170.
9. Altaner, C (2008). Prodrug cancer gene therapy. Cancer Lett 270: 191-201.
10. Vilalta, M, Daano, IR, Bagei J, Aguilar, E, Gambhir, SS, Rubio, N et al. (2009). Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging. Gene Ther 16: 547-557.
11. Miletic, H, Fischer, YH, Giroglou, T, Rueger, MA, Winkeler, A, Li, H et al. (2007). Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma. Clin Cancer Res 13(22 Pt 1): 6761-6768. (Pubitemid 350206814)
12. Mesnil, M, Piccoli, C, Tiraby, G, Willecke, K and Yamasaki, H (1996). Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 93: 1831-1835. (Pubitemid 26079840)
13. Matuskova, M, Hlubinova, K, Pastorakova, A, Hunakova, L, Altanerova, V, Altaner, C et al. (2010). HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 290: 58-67.
14. Nakamizo, A, Marini, F, Amano, T, Khan, A, Studeny, M, Gumin, J et al. (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318. (Pubitemid 40524615)
15. Reiser, J, Zhang, XY, Hemenway, CS, Mondal, D, Pradhan, L and La Russa, VF (2005). Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5: 1571-1584. (Pubitemid 41771848)
16. Djouad, F, Plence, P, Bony, C, Tropel, P, Apparailly, F, Sany, J et al. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844. (Pubitemid 37409409)
17. Vilalta, M, Daano, IR, Bagei J, Gould, D, Santos, M, Garce-Arranz, M et al. (2008). Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 17: 993-1003.
18. Huang, Q, Pu, P, Xia, Z and You, Y (2007). Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. J Neurooncol 82: 239-248. (Pubitemid 46614385)
19. Alieva, M, Bagei JR, Aguilar, E, Soler-Botija, C, Vila, OF, Molet, J et al. (2012). Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. PLoS ONE 7: e35148.
20. Altanerova, V, Cihova, M, Babic, M, Rychly, B, Ondicova, K, Mravec, B et al. (2012). Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer 130: 2455-2463.
21. Bexell, D, Gunnarsson, S, Tormin, A, Darabi, A, Gisselsson, D, Roybon, L et al. (2009). Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190.
22. Bexell, D, Scheding, S and Bengzon, J (2010). Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther 18: 1067-1075.
23. Xu, J, Liu, X, Chen, J, Zacharek, A, Cui, X, Savant-Bhonsale, S et al. (2009). Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am J Physiol, Cell Physiol 296: C535-C543.
24. Choi, SA, Hwang, SK, Wang, KC, Cho, BK, Phi, JH, Lee, JY et al. (2011). Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro-oncology 13: 61-69.
25. Luetzkendorf, J, Mueller, LP, Mueller, T, Caysa, H, Nerger, K and Schmoll, HJ (2010). Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med 14: 2292-2304.
26. Ren, C, Kumar, S, Chanda, D, Kallman, L, Chen, J, Mountz, JD et al. (2008). Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther 15: 1446-1453.
27. Gao, P, Ding, Q, Wu, Z, Jiang, H and Fang, Z (2010). Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett 290: 157-166.
28. Li, M, Yu, J, Li, Y, Li, D, Yan, D and Ruan, Q (2010). CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell Reprogram 12: 405-415.
29. Konno, M, Hamazaki, TS, Fukuda, S, Tokuhara, M, Uchiyama, H, Okazawa, H et al. (2010). Efficiently differentiating vascular endothelial cells from adipose tissue-derived mesenchymal stem cells in serum-free culture. Biochem Biophys Res Commun 400: 461-465.
30. Krebs, LT, Xue, Y, Norton, CR, Shutter, JR, Maguire, M, Sundberg, JP et al. (2000). Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14: 1343-1352. (Pubitemid 30397078)
31. Limbourg, FP, Takeshita, K, Radtke, F, Bronson, RT, Chin, MT and Liao, JK (2005). Essential role of endothelial Notch1 in angiogenesis. Circulation 111: 1826-1832. (Pubitemid 40525149)
32. Yurugi-Kobayashi, T, Itoh, H, Schroeder, T, Nakano, A, Narazaki, G, Kita, F et al. (2006). Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors. Arterioscler Thromb Vasc Biol 26: 1977-1984. (Pubitemid 44253777)
33. Ribeiro, MJ, Phillips, DJ, Benson, JM, Evatt, BL, Ades, EW and Hooper, WC (1995). Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). A representative in vitro model for microvascular endothelium. Thromb Res 79: 153-161.
34. Shao, R, Bao, S, Bai, X, Blanchette, C, Anderson, RM, Dang, T et al. (2004). Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24: 3992-4003. (Pubitemid 38496176)
35. Benedito, R, Rocha, SF, Woeste, M, Zamykal, M, Radtke, F, Casanovas, O et al. (2012). Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484: 110-114.
36. Cihova, M, Altanerova, V and Altaner, C (2011). Stem cell based cancer gene therapy. Mol Pharm 8: 1480-1487.
37. Ray, P, De, A, Min, JJ, Tsien, RY and Gambhir, SS (2004). Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 64: 1323-1330. (Pubitemid 38235600)
38. Bagei JR, Aguilar, E, Alieva, M, Soler-Botija, C, Vila, OF, Claros, S et al. (2013). In vivo bioluminescence imaging of cell differentiation in biomaterials: a platform for scaffold development. Tissue Eng Part A 19: 593-603.
39. Vila, OF, Bagei JR, Navarro, M, Alieva, M, Aguilar, E, Engel, E et al. (2013). Calcium phosphate glass improves angiogenesis capacity of poly(lactic acid) scaffolds and stimulates differentiation of adipose tissue-derived mesenchymal stromal cells to the endothelial lineage. J Biomed Mater Res A 101: 932-941.
40. Roura, S, Bagei JR, Soler-Botija, C, Pujal, JM, Gvez-Mont, C, Prat-Vidal, C et al. (2012). Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivo. PLoS ONE 7: e49447.
41. Carroll, NM, Chase, M, Chiocca, EA and Tanabe, KK (1997). The effect of ganciclovir on herpes simplex virus-mediated oncolysis. J Surg Res 69: 413-417. (Pubitemid 27317891)
42. Marconi, P, Tamura, M, Moriuchi, S, Krisky, DM, Niranjan, A, Goins, WF et al. (2000). Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Mol Ther 1: 71-81.